Overview
EllieMD is a telehealth platform describing itself as more than a telehealth service — a community connecting patients to medical providers, programmes and a licensed partner pharmacy. Its GLP-1 offering is structured differently from most of this market, and the differences are where the concerns live.
Its headline product is twice-weekly oral drops, described as designed to engage GLP-1 pathways involved in appetite signalling, satiety, stomach emptying and post-meal blood sugar response. It also runs a microdose programme offering lower-dose, provider-guided versions of GLP-1 therapies, which the company’s own materials say are not intended for major weight loss, framing them instead around longevity and wellness.
Pricing is layered. Public materials describe a membership of around $40 per month, with promotional messaging that a first vial may cost as little as $117. Independent review coverage describes semaglutide at approximately $229 per month or $687 for 12 weeks, and a premium GLP-1/GIP with B12 formulation at up to $449. A Better Business Bureau complaint record references an $897 charge for a scheduled renewal on a GLP-1/GIP oral drops tier-one subscription.
Three things drive this score down. Compounded and non-injectable oral GLP-1 formulations have substantially weaker supporting evidence than the injectable route — public health reporting has been consistent that GLP-1 drops, pills and patches marketed for weight loss are most likely ineffective. Microdosing GLP-1s has no established clinical evidence base for the outcomes it is marketed around. And the company carries a documented complaint record concerning charges and renewals, alongside independent coverage raising questions about its referral-driven sales model and FDA warnings in the compounded GLP-1 space.
What Makes EllieMD Different
Oral Drops Rather Than Injection
EllieMD leads with twice-weekly oral drops described as engaging GLP-1 pathways. For patients with genuine needle aversion this is superficially attractive — but public health reporting has been consistent that GLP-1 drops, pills and patches marketed for weight loss are most likely ineffective at best.
A Microdosing Programme It Says Is Not for Major Weight Loss
EllieMD offers lower-dose GLP-1 and GLP-1/GIP microdoses framed around longevity, inflammation and wellness. Its own materials state microdosing programmes are not intended for major weight loss. Clinical evidence for microdosing GLP-1s is not established.
A Low Membership With Higher Product Tiers Behind It
The roughly $40 monthly membership is low, but it is a gateway to tiered product pricing. Independent coverage describes semaglutide at around $229 per month and premium GLP-1/GIP with B12 up to $449 — the membership is not the cost of treatment.
A Referral-Driven Model and a Complaint Record
Independent review coverage discusses concerns about EllieMD’s referral-driven sales structure and FDA warnings in the compounded GLP-1 space, and the company has Better Business Bureau complaints on record including disputes over subscription renewal charges.
✓ Pros
- •Low monthly membership — around $40, well below typical care fees
- •Non-injectable option available — twice-weekly oral drops for patients averse to needles
- •Promotional first-vial pricing — public messaging has described a first vial as low as $117
- •Both molecule classes offered — semaglutide and tirzepatide-based formulations
- •Publishes patient education content — a substantial article library and a dosing conversion calculator
- •Provider-guided programmes — treatments described as prescribed through licensed providers and a partner pharmacy
✗ Cons
- •Oral GLP-1 drops have weak supporting evidence — public health reporting indicates such products are most likely ineffective for weight loss
- •Microdosing lacks an established evidence base — and EllieMD states it is not intended for major weight loss
- •BBB complaints on record — including disputes over subscription renewal charges
- •Layered pricing — a low membership fronting product tiers running to $449
- •Large renewal charges reported — a complaint record references an $897 scheduled renewal
- •Referral-driven sales model questioned — raised in independent review coverage
- •Compounded products are not FDA-approved — no agency review of safety, efficacy or manufacturing
- •Partner pharmacy not named publicly — ask which facility dispenses and under what licensure
Our #1 Recommended Provider
The evidence base for oral GLP-1 drops and microdosing does not support what they are marketed to achieve. If you want a GLP-1 programme with an evidence-supported route of administration and straightforward pricing, Coreage RX is our top recommendation.
Medications Offered
Brand-Name or Compounded?
Compounded, with a heavy emphasis on non-injectable and microdose formats. Compounded preparations are not FDA-approved and have not been evaluated by the FDA for safety, efficacy or manufacturing quality. This matters more than usual here, because the formats EllieMD leads with — oral drops and microdoses — are precisely the ones with the least supporting clinical evidence. Public health reporting has been consistent that GLP-1 drops, pills and patches marketed for weight loss are most likely ineffective.
Twice-Weekly GLP-1 Oral Drops
Tiered — confirm your tierDescribed as designed to engage GLP-1 pathways involved in appetite signalling, satiety, stomach emptying and post-meal blood sugar response. Oral GLP-1 formulations of this type have substantially weaker supporting evidence than injectable semaglutide or tirzepatide. Do not assume equivalence with an injection.
GLP-1/GIP Oral Drops
Tiered — a BBB record references $897 on a tier-one renewalThe dual-pathway version of the oral drops product. The same evidence caveat applies, and more strongly — there is no established clinical evidence that an oral drop formulation delivers the outcomes associated with injectable tirzepatide.
Compounded Semaglutide
Approximately $229/month or $687 per 12 weeksPer independent review coverage. The injectable route is the one with a genuine evidence base. If you are considering EllieMD at all, this is the format to discuss with a clinician.
Premium GLP-1/GIP With B12
Up to $449A tirzepatide-based premium formulation with added B12 per independent coverage. Combination formulations are common in the compounded segment; the weight-loss benefit of vitamin additions is not established by strong evidence. Ask what dose of B12 is included.
GLP-1 and GLP-1/GIP Microdoses
Priced separatelyLower-dose, provider-guided versions marketed around longevity, inflammation and wellness. EllieMD’s own materials state microdosing programmes are not intended for major weight loss. Clinical evidence for GLP-1 microdosing is not established.
If you take one thing from this section: the format EllieMD leads with is the format with the least evidence behind it. Before spending anything, ask a clinician who is not selling you the product whether twice-weekly oral GLP-1 drops are a reasonable choice for your goals, and compare against injectable options.
Pricing, Membership & Medication Fees
| Cost Item | What You Pay |
|---|---|
| Membership | Approximately $40/month per public materials |
| Promotional first vial | Public messaging has described a first vial as low as $117 |
| Compounded semaglutide | Approximately $229/month, or $687 per 12 weeks, per independent coverage |
| Premium GLP-1/GIP with B12 | Up to $449 per independent coverage |
| Oral drops tiers | Tiered pricing — a BBB complaint record references an $897 scheduled renewal on a tier-one GLP-1/GIP oral drops subscription |
| Microdose programmes | Priced separately; marketed around longevity rather than major weight loss |
| Insurance | Not used — cash-pay model |
| HSA / FSA | Prescription and eligible medical costs are commonly HSA/FSA eligible; confirm with your plan administrator |
The $40 membership is not the cost of treatment. It is the entry point to tiered product pricing that independent coverage puts between roughly $229 and $449 per month, with at least one documented renewal charge of $897. Before you enrol, establish in writing the total recurring cost of the specific tier you are buying and the exact renewal date and amount.
How EllieMD Works
Ask an Independent Clinician About Oral Drops First
Before you evaluate the price, evaluate the product. Public health reporting has been consistent that GLP-1 drops, pills and patches marketed for weight loss are most likely ineffective. Ask a clinician who is not selling you the product what they think of twice-weekly oral GLP-1 drops.
Establish the Total Recurring Cost, Not the Membership
The $40 membership fronts tiered product pricing. Get in writing what your tier costs, what the renewal amount is, and when it bills — the documented complaints concern exactly this.
Complete the Intake and Provider Review
EllieMD describes connecting patients to medical providers and a licensed partner pharmacy. Be thorough about thyroid history, pancreatitis, gallbladder disease and any family history of medullary thyroid carcinoma or MEN2.
Understand What Microdosing Is and Is Not
EllieMD’s own materials state microdosing programmes are not intended for major weight loss. If weight loss is your goal, a microdose programme is not the product for it, whatever it costs.
Ask Which Partner Pharmacy Dispenses
EllieMD references a licensed partner pharmacy but does not name it publicly. Ask which facility prepares your prescription and whether it is a 503A pharmacy or a 503B outsourcing facility.
Diarise Your Renewal Date
Given the complaint record around scheduled renewal charges, put the renewal date in your calendar with the amount, and know the cancellation process before the charge rather than after it.
Program Details at a Glance
| Detail | EllieMD |
|---|---|
| Consultation process | Online intake connecting patients to medical providers, with treatment described as provider-guided. |
| Eligibility | Adults meeting clinical criteria as assessed by the reviewing provider. Confirm the thresholds applied, particularly for microdose programmes with different stated goals. |
| Provider involvement | Described as provider-guided across programmes. Confirm the channel and response time for clinical questions before you need them. |
| Lab requirements | Not prominently published. Ask whether baseline labs are required or recommended for your situation. |
| Pharmacy fulfillment | A licensed partner pharmacy is referenced but not named publicly. Ask which facility dispenses and whether it is 503A or 503B. |
| Shipping frequency | Aligned to your subscription tier. Confirm the cadence, the renewal date and storage requirements for the specific format you purchase. |
| Support services | A community-oriented model with a substantial patient education library and a pharmacy conversion calculator. Confirm the clinical support channel separately. |
| Membership fee | Approximately $40/month, which is an entry fee rather than the cost of treatment. |
| Medication fee | Tiered and charged separately: semaglutide around $229/month and premium GLP-1/GIP with B12 up to $449 per independent coverage; oral drops tiers priced separately. |
| Cancellation policy | Not prominently published, and the subject of filed complaints regarding renewal charges. Get terms in writing and diarise your renewal date. |
| Refund policy | Not prominently published. A BBB complaint response has characterised a disputed $897 charge as a scheduled renewal rather than an unauthorised charge — understand the renewal terms before enrolling. |
| Insurance | Cash-pay model. Compounded medications are generally not covered by commercial insurance. |
| HSA / FSA | Prescription and eligible medical expenses are commonly HSA/FSA eligible. Confirm with your plan administrator and request itemised receipts. |
| States served | Availability depends on provider licensure in your state. Confirm before enrolling. |
Who EllieMD Is Best For
✓ Best For:
- • Patients who have discussed oral GLP-1 formulations with an independent clinician and understand the evidence limitations
- • Anyone specifically seeking the injectable compounded semaglutide option rather than the drops
- • People who want a low entry membership and will read the tier pricing carefully before committing
✗ Not Best For:
- • Anyone whose primary goal is meaningful weight loss and who would be sold oral drops or a microdose programme
- • Patients who want an evidence-supported route of administration as their default
- • People who want simple, single-figure pricing without membership plus tiered product charges
- • Anyone who has been surprised by a subscription renewal charge before
- • Patients who want brand-name FDA-approved medication or an insurance pathway
- • People who want the dispensing pharmacy named before they order
Limitations to Know Before You Sign Up
- ⚠Oral GLP-1 drops are the product EllieMD leads with, and they are the format with the weakest evidence. Public health reporting has been consistent that GLP-1 drops, pills and patches marketed for weight loss are most likely ineffective, and at best of limited benefit.
- ⚠GLP-1 microdosing does not have an established clinical evidence base for the outcomes it is marketed around, and EllieMD’s own materials state its microdosing programmes are not intended for major weight loss.
- ⚠Pricing is layered. A roughly $40 membership sits in front of product tiers that independent coverage puts between approximately $229 and $449 per month, with a filed complaint referencing an $897 scheduled renewal charge.
- ⚠EllieMD has Better Business Bureau complaints on record, including disputes over subscription renewal charges. Establish the renewal amount and date in writing and diarise it.
- ⚠Independent review coverage discusses concerns about the company’s referral-driven sales structure alongside FDA warnings issued across the compounded GLP-1 telehealth sector.
- ⚠Compounded preparations are not FDA-approved, and the regulatory basis for compounding semaglutide and tirzepatide narrowed after both left the FDA shortage list. The partner pharmacy is not named publicly.
Alternatives to EllieMD
Coreage RX
Our top-rated provider at a flat $99/month for injectable semaglutide and tirzepatide, with 503B sourcing disclosed.
NovoCare Pharmacy
Manufacturer channel for FDA-approved oral Wegovy — an oral GLP-1 that actually has approval and trial data behind it.
Gimme Care
All-inclusive injectable pricing from $130/month on a 3-month cycle with a published refund policy.
Rift
One price at any dose with no mandatory subscription and published shipping and refund policies.
Frequently Asked Questions
How much does EllieMD cost?
Public materials describe a membership of around $40 per month, with promotional messaging that a first vial may cost as little as $117. Independent review coverage describes compounded semaglutide at approximately $229 per month or $687 for 12 weeks, and a premium GLP-1/GIP with B12 formulation at up to $449. A Better Business Bureau record references an $897 charge on a GLP-1/GIP oral drops tier-one subscription renewal. The membership is an entry fee, not the cost of treatment.
Do EllieMD oral drops work for weight loss?
The evidence does not support treating them as equivalent to injectable GLP-1s. Public health reporting has been consistent that GLP-1 products sold as drops, pills and patches for weight loss are most likely ineffective, and at best of limited benefit. If weight loss is your goal, discuss the injectable route with a clinician who is not selling you the product.
What is GLP-1 microdosing and does it work?
Microdosing means lower-dose versions of GLP-1 therapies, marketed around longevity, inflammation and wellness rather than substantial weight loss. Clinical evidence for these outcomes is not established. EllieMD’s own materials state its microdosing programmes are not intended for major weight loss, which is worth taking at face value.
Are there complaints about EllieMD?
Yes. EllieMD has Better Business Bureau complaints on record, including disputes over subscription charges. One documented response characterised a disputed $897 charge as a scheduled renewal payment on a GLP-1/GIP oral drops subscription rather than an unauthorised charge — which underlines the importance of knowing your renewal date and amount before you enrol.
Is EllieMD an MLM?
Independent review coverage discusses concerns about EllieMD’s referral-driven sales structure. We are not in a position to characterise the company’s business model definitively. What we would say is this: when a prescription product reaches you through a referral relationship rather than a clinical one, seek an independent clinical opinion before purchasing.
Are EllieMD products FDA-approved?
No. Compounded preparations are not FDA-approved and have not been reviewed by the agency for safety, efficacy or manufacturing quality. The regulatory position of compounded GLP-1s narrowed after semaglutide and tirzepatide left the FDA shortage list.
Which pharmacy dispenses EllieMD medication?
EllieMD references a licensed partner pharmacy but does not name it publicly. Ask directly which facility prepares your prescription and whether it is a 503A pharmacy or a 503B outsourcing facility.
What is the B12 doing in the premium formulation?
Independent coverage describes a premium GLP-1/GIP with B12 formulation at up to $449. Combination formulations are common across the compounded segment and are generally framed around energy and tolerability. The weight-loss benefit of vitamin additions is not established by strong evidence — ask what dose is included and discuss it with a clinician.
The Bottom Line
EllieMD earns 2.0 out of 5 stars — and the reason is not price or service, it is the products themselves.
The formats this company leads with are the formats with the least evidence behind them. Twice-weekly oral GLP-1 drops are marketed as engaging GLP-1 pathways for appetite and satiety, but public health reporting has been consistent that GLP-1 products sold as drops, pills and patches for weight loss are most likely ineffective. Microdosing has no established clinical evidence base for what it is marketed around — and EllieMD’s own materials concede the programmes are not intended for major weight loss. A patient looking for meaningful weight loss can spend a great deal of money here on products that are not designed to deliver it.
The commercial structure compounds the problem. A low $40 membership fronts tiered product pricing that independent coverage puts between roughly $229 and $449 per month, and the company carries Better Business Bureau complaints including a documented dispute over an $897 scheduled renewal charge. Independent coverage also raises questions about a referral-driven sales structure, which is a poor fit for prescription medication where the person recommending it should not have a financial stake in your purchase.
Our recommendation: if you are considering EllieMD, speak first to a clinician with no financial interest in what you buy, and ask specifically about oral GLP-1 drops versus injectable therapy. If injection is a genuine barrier, NovoCare Pharmacy supplies FDA-approved oral Wegovy, which has approval and trial data behind it. If you can inject, Coreage RX at a flat $99 delivers the evidence-supported route for less than most EllieMD tiers.
Disclosure:
This review is based on publicly available information from EllieMD’s own website at elliemd.com, including its weight loss, microdose and product pages, together with independent review coverage, publicly filed Better Business Bureau complaint records, and public health reporting on GLP-1 supplements and non-injectable GLP-1 products, current as of August 27, 2026. Pricing figures attributed to independent coverage are cited as reported and should be confirmed directly with the company. Presidential GLP-1 may receive compensation from some providers featured on this site, which helps us provide free, independent reviews; we do not have a compensation relationship with EllieMD. Complaint records reflect the experiences of the patients who filed them. Compounded medications are not FDA-approved and their regulatory position narrowed after semaglutide and tirzepatide left the FDA shortage list. We do not sell, dispense, or ship medication.
⚕ Medical Disclaimer:
This review is for informational purposes only and is not medical advice, diagnosis, or treatment. Prescription weight-management medications carry serious risks and contraindications; GLP-1 receptor agonists carry a boxed warning for thyroid C-cell tumors. Only a licensed clinician who knows your medical history can determine whether any weight-management medication is appropriate for you. Never start, stop, or change a prescription based on this page. If you experience severe abdominal pain, persistent vomiting, signs of an allergic reaction, or other concerning symptoms, seek medical care immediately. See our full medical disclaimer.
Or check out our top-rated provider